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Endovenous Varicose vein 
treatment are minimally invasive and 
office based 
•Thermal energy (+ tumescence anaethesia) 
•Radiofrequency ablation 
•Laser 
•steam 
•Sclerotherapy 
•Non thermal ablation 
•Mechanical and sclerosant (ClariVein) 
•Cyanoacylate (Venaseal) 
静脉腔内静脉曲张治疗 
After successful cannulation of the GSV, a guidewire is passed under ultrasound 
guidance. In the meantime, the cyanoacylate is being drawn up and prepared. 
Cyanoacrylate Glue (VenaSeal) 

Mechanicochemical ablation (ClariVein) 
Completion duplex: successful 
obliteration of great saphenous vein 
Completion duplex: absence of 
thrombus or clots in deep 
femoral vein 
Methods 
• Single center prospective, non randomized 
comparative study for evaluation of safety and 
efficacy of VenaSeal v.s. Clarivein 
• Primary outcomes: 
– Complications 
– Clinical recurrence of 
varicosity and re-
intervention 
– Radiological duplex 
ultrasound GSV 
obliteration rate: 4 days, 
1 week, 1 month, 3 
months, 6 months 
Patients’ characteristics 
VenaSeal (n=22) ClariVein (n=24) P value 
Median age 62 (range 39-80) 60.5 (range 44-76) NS* 
Male: Female 6:16 8:16 NS^ 
Co-morbidities 
- DM 
- HT 
- Cardiac  
- Renal 
- COPD 
 
2/22 
9/22 
6/22 
1/22 
0/22 
 
0/24 
4/24 
2/24 
0/24 
0/24 
 
NS^ 
NS^ 
NS^ 
NS^ 
NS^ 
Sides 
- Unilateral 
- Bilateral 
 
1/22 
21/22 
 
18/24 
6/24 
 
<0.001^ 
VenaSeal group: 43 legs in 22 patients 
ClariVein group: 30 legs in 18 patients  
*Student t test, ^chi square test 
Leg varicose vein characteristics 
VenaSeal (n=43) ClariVein (n=30) P value 
CEAP clinical 
classification 
- C3 
- C4a 
- C4b 
- C5 
- C6 
 
28 
12 
1 
1 
1 
 
15 
9 
3 
0 
3 
 
 
NS^ 
Mean diameter of 
GSV (mm) 
7.2 (range 3.9-11.4) 6.5 (range 5.0-10.0) NS* 
Mean treatment 
length of GSV (cm) 
28.4 (range 20-33) 32.8 (range 25-38) 0.001* 
*Student t test, ^chi square test 
Operative outcomes 
VenaSeal 
(n=43) 
ClariVein 
(n=30) 
P value 
Mean operative 
time (minutes) 
64.6 (range 28-
99) 
72.0 (range 25-
125) 
NS* 
Primary success 43/43 (100%) 29/30 (96.7%) NS^ 
Access 
- Percutaneous 
- Open 
 
43/43 (100%) 
0/43 
 
27/30 (90%) 
3/30 
 
NS^ 
*Student t test, ^chi square test 
One procedure failure for ClariVein group due to 
very tortuous GSV; and hence excluded from 
subsequent analysis 
Post-operative complications 
VenaSeal 
(n=43) 
ClariVein 
(n=29) 
Deep Vein thrombosis 0 0 NS^ 
Thrombus extension to deep vein 0 3 NS^ 
Parenthesis 1 0 NS^ 
Weakness 0 0 NS^ 
Wound infection 1 0 NS^ 
Cellulitis 0 1 NS^ 
Symptomatic thrombophlebitis 0 2 NS^ 
^chi square test 
Clinical outcomes 
• VenaSeal group: median follow up period 9 
months (range 5-12) 
• ClariVein group: median follow up period 9.5 
months (range 1-15) 
• No clinical recurrence or secondary 
intervention 
 
ClariVein: Hazard ratio 1.40,  
95% CI 0.31-6.28, p=0.661 
ClariVein 
VenaSeal 
Predictors of recanalization 
Hazard 
ratio 
95% 
CI 
P 
value 
ClariVein 1.40 0.31- 
6.28 
0.661 
Mean 
diameter 
>= 8mm 
3.10 0.69- 
13.89 
0.139 
Mean 
treatment 
length 
<20cm 
3.05 0.53- 
17.62 
0.212 
Diameter <8mm 
>=8mm 
Conclusion 
• Both treatment modalities were safe with 
comparable clinical and radiological outcomes 
• Trend towards more recanalization in GSV with 
larger diameter 
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